is mounjaro glp-1 mounjaro®（GLP-1/GIP） Tirzepatide (Mounjaro)

The substantial weight reduction observed with tirzepatide monotherapy (15-21% body weight in clinical trials) suggests that any perceived benefits likely reflect tirzepatide's pharmacological effects rather than synergistic action

Any current online price reflects unapproved research material, not a regulated medication

We believe in absolute transparency - since in third-party marketing we need complete confidence

Solution : Implement cost containment strategies like step therapy, prior authorization, and exploring alternative medications to help manage the financial impact of GLP-1s

Statements Acknowledgments This work was supported by grants from University of PadovaMURST ex-60%. Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest

What I find underappreciated is the supplier quality dimension